Measurement of micronucleated erythrocytes and DNA damage during chronic ingestion of phenolphthalein in transgenic female mice heterozygous for the p53 gene

Environmental and Molecular Mutagenesis

Volumn 31, Issue 2, 1998, Pages 113-124

  Tice, Raymond R ^a   Furedi Machacek, Marianna ^a   Satterfield, Diane ^a   Udumudi, Anu ^a   Vasquez, Marie ^a   Dunnick, June K ^b  

^a INTEGRATED LABORATORY SYSTEMS   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Alkaline single cell gel electrophoresis; DNA damage; Erythrocytes; Genotoxicity; Kinetochore; Micronuclei; P53 deficient transgenic mouse

Indexed keywords

LAXATIVE; PHENOLPHTHALEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTROMERE; CONTROLLED STUDY; DNA DAMAGE; DRUG CARCINOGENICITY; ERYTHROCYTE; FEMALE; GEL ELECTROPHORESIS; GENOTOXICITY; LONG TERM EXPOSURE; MICRONUCLEUS; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

ADMINISTRATION, ORAL; ANIMALS; CATHARTICS; DIET; DNA; DNA DAMAGE; ERYTHROCYTES, ABNORMAL; FEMALE; GENES, P53; HETEROZYGOTE; KINETOCHORES; LIVER; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; PHENOLPHTHALEIN; PHENOLPHTHALEINS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0031968773     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2280(1998)31:2<113::AID-EM3>3.0.CO;2-N     Document Type: Article

References (52)

1. Abruzzo MA, Hassold TJ (1995): Etiology of nondisfunction in humans. Environ Mol Mutagen 25(Suppl 26):38-47.
2. AHFS (American Hospital Formularly Service) (1995): AHFS Drug Information® 95 (GK McEvoy, ed). Bethesda, MD: American Society of Health-System Pharmacist, pp 1986-1995.
3. Bonin AM, Farquaharson JB, Baker RSU (1981): Mutagenicity of arylmethane dyes in Salmonella. Mutat Res 89:21-34.
4. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RJ, Radkind WH, Reid BJ (1995): A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
5. CSGMT (Collaborative Study Group for the Micronucleus Test) (1988): Strain differences in the micronucleus test. Mutat Res 204:307-316.
6. Degrassi F, Tanzarella C (1988): Immunofluorescent staining of kineto-chores in micronuclei: A new assay for the detection of aneuploidy. Mutat Res 203:339-345.
7. Deppert W (1994): The yin and yang of p53 in cellular proliferation. Semin Cancer Biol 5:187-202.
8. Dietz DD, Elwell MR, Chapin RE, Shelby MD, Thompson MB, Filler R, Stedham MA (1992): Subchronic (13-week) toxicity studies of oral phenolphthalein in Fischer 344 rats and B6C3F1 mice. Fundam Appl Toxicol 18:48-58.
9. Donehower LA (1996): Effects of p53 mutation on tumor progression: Recent insights from mouse tumor models. Biochim Biophys Acta 1242:171-176.
10. Donehower LA, Bradley A (1993): The tumor suppressor p53. Biochim Biophys Acta 1155:181-205.
11. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A (1992): Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215-221.
12. Dunnick JK, Hailey JR (1996): Phenolphthalein exposure causes multiple carcinogenic effects in experimental model systems. Cancer Res 56:4922-4926.
13. Dunnick JK, Herbert RA, Hardisty JF, Seely J, Furedi-Machacek EM, Foley JF, Stasiewicz S, Lacks G, French JE (1997): Phenolphthalein rapidly induces malignant hematopoietic tumors and loss of heterozygosity in the p53 wild type allele in heterozygous p53 deficient (+/-) mice. Toxicol Pathol 25:533-540.
14. Eastmond DA, Tucker JD (1989): Identification of aneuploidy-inducing agents using cytokinesis-blocked human lymphocytes and an antikinetochore antibody. Environ Mol Mutagen 13:34-43.
15. Fairbairn DW, Olive PL, O'Neill KL (1995): The Comet assay: A comprehensive review. Mutat Res 339:37-59.
16. Fujita H, Mizuo A, Hiraga H (1976): Mutagenicity of dyes in the microbial system. Ann Rep Tokyo Metr Res Lab PH 27-2:153-158.
17. Fuscoe JC, Afshari AJ, George MH, DeAngelo AB, Tice RR, Allen JW (1996): In vivo genotoxicity of dichloroacetic acid. Evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assay. Environ Mol Mutagen 27:1-9.
18. Goldsworthy TL, Recio L, Brown K, Donehower LA, Mirsalis JD, Tennant RW, Purchase IFH (1994): Transgenic animals in toxiclogy. Fundam Appl Toxicol 22:8-19.
19. Harris CC (1996): p53 Tumor suppressor gene: From the basic research laboratory to the clinic - An abridged historical perspective. Carcinogenesis 17:1187-1198.
20. Harvey M, Vogel H, Morris D, Bradley A, Bernstein A, Donehower LA (1995): A mutant p53 transgene accelerates tumor development in heterozygous but not nullizygous p53 deficient mice. Nat Genet 9:305-311.
21. Hayashi M, Tice RR, MacGregor JT, Anderson D, Blakey DH, Kirsh-Volders M, Oleson FB Jr, Pacchierotti F, Romogna F, Shimada H, Sutou S, Vannier B (1994): In vivo rodent erythrocyte micronucleus assay. Mutat Res 312:293-304.
22. Hecht F, Hecht BK (1987): Aneuploidy in humans: Dimensions, demography, and dangers of abnormal numbers of chromosomes. In Vig BK, Sandberg AA (eds): "Aneuploidy, Part A: Incidence and Etiology." New York: Alan R. Liss, pp 9-49.
23. Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW, Salamone MF (1983): The induction of micronuclei as a measure of genotoxicity. Mutat Res 123:61-118.
24. Integrated Laboratory Systems (1990): Micronucleus Assay Data Management and Analysis System. Las Vegas, NV: Environmental Monitoring System Laboratory, USEPA.
25. Kada T, Tutikawa K, Sadaie Y (1972): In vitro and host-mediated 'recassay' procedures for screening chemical mutagens; and phloxine, a mutagenic red dye detected. Mutat Res 16:165-174.
26. Luke CA, Tice RR, Drew RT (1988a): The effect of exposure regimen and duration on benzene-induced bone marrow damage in mice. I. Sex comparisons in DBA/2 mice. Mutat Res 203:251-272.
27. Luke CA, Tice RR, Drew RT (1988b): The effect of exposure regimen and duration on benzene-induced bone marrow damage in mice. II. Strain comparisons involving B6C3F1, C57BL/6 and DBA/2 mice. Mutat Res 203:273-296.
28. MacGregor JT, Wehr CM, Gould DH (1980): Clastogen-induced micronuclei in peripheral blood erythrocytes: The basis of an improved micronucleus test. Environ Mutagen 2:509-514.
29. MacGregor JT, Farr S, Tucker JD, Heddle JA, Tice RR, Turteltaub KW (1995): New molecular endpoints and methods for routine toxicity testing. Fundam Appl Toxicol 26:156-173.
30. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, Zeiger E (1986): Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 8(Suppl 7):1-119.
31. 1 Mice. Research Triangle Park, NC: NTP TR 465.
32. OECD (1996): Guideline for the testing of chemicals. Mammalian erythrocyte micronucleus test. Guideline 474, September, 1995 revision.
33. Oshimura M, Koi M, Ozawa N, Sugawara O, Lamb PW, Barrett JC (1988): Role of chromosome loss in ras/myc-induced Syrian hamster tumors. Cancer Res 48:16-23.
34. Preston RJ, Au W, Bender MA, Brewen JG, Carrano AV, Heddle JA, McFee AF, Wolff S, Wassom JS (1983): Mammalian in vivo and in vitro cytogenetic assays: A report of the Gene-Tox Program. Mutat Res 87:143-188.
35. Preston RJ, Dean BJ, Galloway S, Holden H, McFee AF, Shelby M (1987): Mammalian in vivo cytogenetic assays: Analysis of chromosome aberrations in bone marrow cells. Mutat Res 189:157-165.
36. Schlegel R, MacGregor JT (1982): The persistence of micronuclei in peripheral blood erythrocytes: Detection of chronic chromosome breakage in mice. Mutat Res 104:367-369.
37. Shelby MD (1988): The genetic toxicity of human carcinogens and its implications. Mutat Res 204:3-15.
38. Shelby MD, Erexson GL, Hook GJ, Tice RR (1993): Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ Mol Mutagen 21:160-179.
39. Singh NP, McCoy MT, Tice RR, Schneider EL (1988): A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184-191.
40. Soloman E, Borrow J, Goddard A (1991): Chromosome aberrations and cancer. Science 254:1153-1160.
41. Tennant RW, French JE, Spalding JW (1995): Identification of chemical carcinogens and assessing potential risk in short term bioassays using transgenic mouse models. Environ Health Perspect 103:943-950.
42. Tice RR (1995): The single cell gel/comet assay: A microgel electrophoretic technique for the detection of DNA damage and repair in individual cells. In Phillips DH, Venitt S (eds): "Environmental Mutagenesis." Oxford: Bios Scientific Publishers, pp 315-339.
43. Tice RR, Ivett JL (1985): Cytogenetic analysis of bone marrow damage. In Irons RD (ed): "Toxicology of the Blood and Bone Marrow." New York: Raven Press, pp 119-140.
44. Tice RR, Erexson GL, Hilliard CJ, Huston JL, Boehm RM, Gulati D, Shelby MD (1990): Effect of treatment protocol and sample time on the frequencies of micronucleated polychromatic erythrocytes in mouse bone marrow and peripheral blood. Mutagenesis 5: 313-321.
45. Tice RR, Strauss GHS, Peters WP (1992): High dose combination alkylating agents with autologous bone marrow support in patients with breast cancer: Preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutat Res 271:101-113.
46. Tice RR, Nylander-French LA, French JE (1997a): Absence of systemic in vivo genotoxicity after dermal exposure to ethyl acrylate and tripropylene glycol diacrylate in Tg.AC (v-Ha-ras) mice. Environ Mol Mutagen 29:240-249.
47. Tice RR, Yager JW, Andrews PA, Crecelius E (1997b): Effect of hepatic methyl donor status on urinary excretion and DNA damage in B6C3F1 mice treated with sodium arsenite. Mutat Res 386:315-334.
48. Udumudi A, Tice RR (1997): The single cell gel (SCG) assay: Optimal freezing methods for maintaining DNA integrity prior to analysis for DNA damage. Environ Mol Mutagen 29(Suppl 28):53.
49. Vasquez M, Tice RR (1997): Comparative analysis of apoptosis versus necrosis using the single cell gel (SCG) assay. Environ Mol Mutagen 29(Suppl 28):52.
50. Vig BK, Sternes KL (1991): Centromeres without kinetochore proteins. Another mechanism for the origin of aneuploidy in neoplasia. Cancer Genet Cytogenet 51:269-272.
51. Vogelstein B, Kinzler KW (1992): p53 Function and dysfunction. Cell 70:523-526.
52. Witt KL, Gulati DK, Kaur P, Shelby MD (1995): Phenolphthalein: Induction of micronucleated erythrocytes in mice. Mutat Res 341:151-160.